Event Brief
Mar 26, 2026 at 12:06 AM ET
China's Drug Makers Target Weight-Loss Market After Patent Expiry
By The BriefBrief
With Novo Nordisk's patent expired, at least 10 Chinese weight-loss drugs seek approval in a booming market.
WHO: Chinese drug manufacturers
WHAT: Seeking regulatory approval for weight-loss drugs
WHEN: Mar 25, 2026 at 11:00 PM ET
WHERE: China
WHY: Novo Nordisk's semaglutide lost patent protection on March 20.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21430 of 21430
Same format. Every time.
Continue reading — sign in or create a free account with
